Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 15;14(11):8234–8242.

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

AJTR Copyright © 2022

PMC Copyright notice

Improvement of patients’ immune function. A. There was no significant difference in IgA between the two groups before treatment (P>0.05). After treatment, IgA of the two groups decreased significantly (P<0.001), with a significantly lower level in the research group than that in the control group (P<0.001). B. There was no significant difference in IgG between the two groups before treatment (P>0.05). After treatment, IgG of the two groups decreased significantly (P<0.001), with a significantly lower level in the research group than that in the control group (P<0.001). C. There was no significant difference in IgM between the two groups before treatment (P>0.05). After treatment, IgM of the two groups decreased significantly (P<0.001), with a significantly lower level in the research group than that in the control group (P<0.001). Notes: *P<0.05, **P<0.01, and ***P<0.001. IgA, immunoglobulin A; IgG, immunoglobulin G; IgM, immunoglobulin M.